Literature DB >> 17934910

Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis.

Damiano Baldassarre1, Arienne De Jong, Mauro Amato, J Pablo Werba, Samuela Castelnuovo, Beatrice Frigerio, Fabrizio Veglia, Elena Tremoli, Cesare R Sirtori.   

Abstract

BACKGROUND: Different soluble molecules involved in inflammation, endothelial damage, or hemostasis are recognized as potential cardiovascular risk markers. Studies to assess the role of these markers in the atherosclerotic process by evaluating their relationship to carotid intima-media thickness (C-IMT) tend to provide contrasting results.
PURPOSE: To perform a review of studies addressing the association between C-IMT and soluble markers and to investigate whether the observed inconsistencies could be explained by the characteristics of the patients included in different studies, for example prevalence of atherosclerotic disease (atherosclerotic burden), gender, age, or occurrence of specific vascular risk factors (VRFs). DATA SOURCES: PubMed and Embase (January 1990 to March 2006). STUDY SELECTION: Articles in English reporting original cross-sectional studies. DATA EXTRACTION: Two authors independently extracted data on study design, population, sample size, ultrasonic methodology, and statistical approach. DATA SYNTHESIS: Despite the marked heterogeneity of results presented in the literature, meta-analysis established that studies showing positive associations between C-IMT and plasma levels of C-reactive protein (CRP) or fibrinogen are in the majority. Funnel plot analyses suggested the absence of an important publication bias. Data on the relationships between C-IMT and other soluble markers are by contrast scanty, contradictory, or unconfirmed by multivariate (as opposed to univariate) analyses, and the freedom from publication bias here cannot be vouched for. The degree of atherosclerotic burden in the population studied does not account for the heterogeneity of findings reported. Gender, noninsulin-dependent diabetes mellitus (NIDDM) and hypercholesterolemia influence the association between C-IMT and CRP. Blood pressure and hypercholesterolemia influence the association between C-IMT and fibrinogen. For all the other soluble markers considered, the number of groups was too small for this kind of statistical considerations. LIMITATIONS: Heterogeneity in ultrasound methodologies and in statistical approach limited comparability between studies. For most soluble markers, publication bias of positive results cannot be excluded.
CONCLUSIONS: Only CRP and fibrinogen seem to be unequivocally related to C-IMT. For all the other soluble markers considered, no clear-cut conclusions can be drawn.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17934910     DOI: 10.1080/07853890701645399

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  23 in total

Review 1.  Imaging subclinical atherosclerosis: is it ready for prime time? A review.

Authors:  Leticia Fernández-Friera; Borja Ibáñez; Valentín Fuster
Journal:  J Cardiovasc Transl Res       Date:  2014-08-14       Impact factor: 4.132

2.  Associations between Inflammatory Markers and Subclinical Atherosclerosis in Middle-aged White, Japanese-American and Japanese Men: The ERA-JUMP Study.

Authors:  Shin-Ya Nagasawa; Takayoshi Ohkubo; Kamal Masaki; Emma Barinas-Mitchell; Katsuyuki Miura; ToddB Seto; Aiman El-Saed; Takashi Kadowaki; Bradley J Willcox; Daniel Edmundowicz; Aya Kadota; Rhobert W Evans; Sayaka Kadowaki; Akira Fujiyoshi; Takashi Hisamatsu; Marianne H Bertolet; Tomonori Okamura; Yasuyuki Nakamura; Lewis H Kuller; Hirotsugu Ueshima; Akira Sekikawa
Journal:  J Atheroscler Thromb       Date:  2014-11-29       Impact factor: 4.928

3.  High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population.

Authors:  Giuseppe De Luca; Monica Verdoia; Ettore Cassetti; Alon Schaffer; Chiara Cavallino; Virginia Bolzani; Paolo Marino
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

4.  Imaging Atherosclerosis by Carotid Intima-media Thickness in vivo: How to, Where and in Whom ?

Authors:  Roxana Onut; Assoc Prof Serban Balanescu; Dana Constantinescu; Lucian Calmac; Mugur Marinescu; Prof Maria Dorobantu
Journal:  Maedica (Buchar)       Date:  2012-06

5.  Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study.

Authors:  David Green; Nancy Foiles; Cheeling Chan; Pamela J Schreiner; Kiang Liu
Journal:  Atherosclerosis       Date:  2008-07-03       Impact factor: 5.162

Review 6.  Iron and atherosclerosis: nailing down a novel target with magnetic resonance.

Authors:  Travis P Sharkey-Toppen; Arun K Tewari; Subha V Raman
Journal:  J Cardiovasc Transl Res       Date:  2014-03-04       Impact factor: 4.132

7.  Hypertonic cardiopulmonary bypass primes and endothelial damage.

Authors:  Michael Poullis; Richard Warwick; Priya Sastry; Eustace Fontaine
Journal:  J Extra Corpor Technol       Date:  2008-12

8.  Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.

Authors:  Jonathan Graf; Rebecca Scherzer; Carl Grunfeld; John Imboden
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

9.  The use of carotid artery ultrasonography in different clinical conditions.

Authors:  Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2009-07-07

10.  Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.

Authors:  N B Adams; P L Lutsey; A R Folsom; D H Herrington; C T Sibley; N A Zakai; S Ades; G L Burke; M Cushman
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.